COVID India Updates: Bleeding, clotting events following vaccination 'minuscule' in India

Maharashtra recorded as many as 26,616 coronavirus cases on Monday, taking the tally of infections in the state to 54,05,068, the death toll increased to 82,486 with 516 new fatalities. As many as 48,211 patients were discharged from hospitals, taking the number of recovered patients to 48,74,582, The number of active cases stands at 4,45,495.

Maharashtra's recovery rate of COVID-19 cases is 90.19 per cent, while the fatality rate is 1.53 per cent.

Bleeding and clotting cases following COVID-19 vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, a report submitted by the National AEFI (Adverse Event Following Immunization) Committee to the Ministry of Health & Family Welfare said.

Read the full story

Delhi recorded as many as 4,524 fresh coronavirus cases on Monday. With this, the tally of COVID-19 cases in the national capital has reached over 13.98 lakh, while the death toll mounted to 21,846. As many as 340 fatalities have been recorded in the last 24 hours, according to the latest bulletin issued by the Delhi health department.

This is the fourth consecutive day when Delhi has recorded less than 10,000 cases in a day. The COVID-19 positivity rate in the national capital dipped to 8.42 per cent.

According to a health bulletin issued by the Delhi government, 53,756 COVID-19 tests were conducted in the last 24 hours.

The Centres for Disease Control and Prevention followed with recommendations endorsing use in this age group after their advisory group meeting on May 12. The American Academy of Pediatrics also supports this decision. Dr Debbie-Ann Shirley is an associate professor of pediatrics at the University of Virginia specialising in paediatric infectious diseases.

READ MORE

India's daily spike of coronavirus cases remained below the 3 lakh mark for the first time in nearly 26 days as only 2,81,386 fresh infections were recorded in the last 24 hours, according to the Union Health Ministry's data on Monday. On April 22, the country achieved a grim milestone in its fight against the raging coronavirus as it reported over 3 lakh new cases in a 24-hour period for the first time since the pandemic began last year. The Ministry of Health and Family Welfare reported 4,106 Covid-related new deaths in the country and 3,78,741 fresh recoveries during the 24-hour period. The cumulative caseload stands at 2,49,65,463, including 2,11,74,076 recoveries, 35,16,997 active cases and 2,74,390 deaths.

Maharashtra on Sunday saw Covid-19 new infections drop but the state's deaths kept increasing to cross 81,000, though there was also an increase in the recovery rate, health officials said. Against 960 deaths on Saturday, the state fatalities were at 974, taking the toll to 81,486 now. Remaining below the 50,000-level, the cases dropped from 34,848 to 34,389, to take the tally to 3,78,452 now.

Seers, saints and volunteers of Rashtriya Swayamsevak Sangh (RSS) and other frontal Hindu organizations, along with lakhs of Hindu families, will recite the 'Hanuman Chalisa' eleven times on Tuesday to drive away the Coronavirus. The event will take place in Kashi Prant comprising 26 districts of eastern Uttar Pradesh.

"Formulated by RDO and DRL, 2-deoxy-D-glucose (2-DG) will prove effective in covid. This is a great example of the scientific prowess of our country. For this, I congratulate DRDO, and all the institutions involved in the R&D of this drug, on my behalf. About this drug, I would say that this is a new ray of hope and hope. But right now, we do not need to be relaxed, nor do we need to get tired, and stop. Because this wave has come for the second time, and there is nothing definite about this even further. We have to take steps with full caution," says Defense Minister.

Pursuing Prime Minister Narendra Modi's call for preparedness against the pandemic, DRDO took the initiative of developing anti-COVID therapeutic application of 2-DG. In April 2020, during the first wave of the pandemic, INMAS-DRDO scientists conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth.

Based on these results, Drugs Controller General of India's (DCGI) Central Drugs Standard Control Organization (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2020.

The information of the drug launch was made on Rajnath Singh's official Twitter handle and read,"Raksha Mantri Rajnath Singh will release the first batch of anti-Covid drug 2DG via video conferencing facility tomorrow at 10.30 AM. The drug has been developed by DRDO's Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories."

And today, the medicine was launched. Have a look at the video here:

Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.